<DOC>
	<DOCNO>NCT00660764</DOCNO>
	<brief_summary>In observational multi-centre study ( HEROS ) , effect start treatment rosuvastatin assess , low-density lipoprotein cholesterol ( LDL-C ) goal achievement , patient dissimilar high-risk profile treat cholesterol lower drug least past three month . Also set-up cost rosuvastatin treatment proportional change LDL-C high-density lipoprotein cholesterol ( HDL-C ) study .</brief_summary>
	<brief_title>Assessment Efficacy Rosuvastatin Patient Groups With Dissimilar Risk Profile Observational Study ( HEROS )</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>patient treat cholesterol lower drug least past three month , LDLC 3.2 mmol/l . According advise CBO , could include one follow risk group : secondary prevention , DM primary prevention . The general practice investigator make decision start treatment rosuvastatin irrespective study participation . Patient approve place anonymous result disposal AstraZeneca Patients symptom myalgia , myopathy liver function insufficiency ( include raise serum transaminase ) bear causal relation treatment statin , patient familiar dyslipidemia and/or patient contraindication treatment rosuvastatin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>cholesterol</keyword>
	<keyword>coronary heart disease</keyword>
	<keyword>rosuvastatin</keyword>
	<keyword>LDL-C goal</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>secondary prevention</keyword>
	<keyword>primary prevention</keyword>
	<keyword>CVA</keyword>
</DOC>